Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Sarepta Therapeutics (SRPT) Stock Price & Analysis
2,391 Followers
SRPT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$61.28 - $159.84
Previous Close$122.69
Volume2.69M
Average Volume (3M)1.34M
Market Cap
$10.79B
Enterprise Value$10.42B
Total Cash (Recent Filing)$1.99B
Total Debt (Recent Filing)$1.62B
Price to Earnings (P/E)-15.3
Beta0.21
Next Earnings
May 03, 2023EPS Estimate
-$1.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-8.03
Shares Outstanding87,782,576
10 Day Avg. Volume908,427
30 Day Avg. Volume1,340,997
Standard Deviation0.17
R-Squared0.10
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)25.38
Price to Sales (P/S)16.21
Price to Cash Flow (P/CF)54.10
P/FCF Ratio-42.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.17
Enterprise Value/Gross Profit13.14
Enterprise Value/Ebitda-17.52
Forecast
1Y Price Target
$168.00Price Target Upside27.87% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering19
Sarepta Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SRPT FAQ
What was Sarepta Therapeutics’s price range in the past 12 months?
Sarepta Therapeutics lowest stock price was $61.28 and its highest was $159.84 in the past 12 months.
What is Sarepta Therapeutics’s market cap?
Currently, no data Available
When is Sarepta Therapeutics’s upcoming earnings report date?
Sarepta Therapeutics’s upcoming earnings report date is May 03, 2023 which is in 44 days.
How were Sarepta Therapeutics’s earnings last quarter?
Sarepta Therapeutics released its earnings results on Feb 28, 2023. The company reported -$1.24 earnings per share for the quarter, beating the consensus estimate of -$1.474 by $0.234.
Is Sarepta Therapeutics overvalued?
According to Wall Street analysts Sarepta Therapeutics’s price is currently Undervalued.
Does Sarepta Therapeutics pay dividends?
Sarepta Therapeutics does not currently pay dividends.
What is Sarepta Therapeutics’s EPS estimate?
Sarepta Therapeutics’s EPS estimate is -$1.33.
How many shares outstanding does Sarepta Therapeutics have?
Sarepta Therapeutics has 87,981,890 shares outstanding.
What happened to Sarepta Therapeutics’s price movement after its last earnings report?
Sarepta Therapeutics reported an EPS of -$1.24 in its last earnings report, beating expectations of -$1.474. Following the earnings report the stock price went up 19.242%.
Which hedge fund is a major shareholder of Sarepta Therapeutics?
Among the largest hedge funds holding Sarepta Therapeutics’s share is Sands Capital Management LLC. It holds Sarepta Therapeutics’s shares valued at 279M.
---
Sarepta Therapeutics Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$168.00 (27.87% Upside)
$168.00 (27.87% Upside)
Blogger Sentiment
Bullish
SRPT Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 176.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $698.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.4%
Last 30 Days ▲ 14.5%
Last 30 Days ▲ 14.5%
News Sentiment
Positive
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
55.04%
12-Months-Change
Fundamentals
Return on Equity
-107.16%
Trailing 12-Months
Asset Growth
-0.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Sarepta Therapeutics
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.
---
---